BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20599528)

  • 1. Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan.
    Amorim Cde M; Couto AG; Netz DJ; de Freitas RA; Bresolin TM
    Nanomedicine; 2010 Dec; 6(6):745-52. PubMed ID: 20599528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and antioxidant activity of Elsholtzia splendens extract-loaded nanoparticles.
    Lee JS; Kim GH; Lee HG
    J Agric Food Chem; 2010 Mar; 58(6):3316-21. PubMed ID: 20187637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.
    Nafee N; Schneider M; Schaefer UF; Lehr CM
    Int J Pharm; 2009 Nov; 381(2):130-9. PubMed ID: 19450671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
    Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
    Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
    Fan W; Yan W; Xu Z; Ni H
    Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cavitation effect on chitosan nanoparticle size: a possible approach to protect drugs from ultrasonic stress.
    Floris A; Meloni MC; Lai F; Marongiu F; Maccioni AM; Sinico C
    Carbohydr Polym; 2013 Apr; 94(1):619-25. PubMed ID: 23544582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idebenone loaded solid lipid nanoparticles: calorimetric studies on surfactant and drug loading effects.
    Sarpietro MG; Accolla ML; Puglisi G; Castelli F; Montenegro L
    Int J Pharm; 2014 Aug; 471(1-2):69-74. PubMed ID: 24845103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and in vitro drug release of magnetic N-benzyl-O-carboxymethylchitosan nanoparticles loaded with indomethacin.
    Debrassi A; Bürger C; Rodrigues CA; Nedelko N; Ślawska-Waniewska A; Dłużewski P; Sobczak K; Greneche JM
    Acta Biomater; 2011 Aug; 7(8):3078-85. PubMed ID: 21601660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles.
    Keawchaoon L; Yoksan R
    Colloids Surf B Biointerfaces; 2011 May; 84(1):163-71. PubMed ID: 21296562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
    Lin AH; Liu YM; Ping QN
    Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.